Health and Fitness Health and Fitness
Wed, May 19, 2010
[ 05:30 AM ] - Market Wire
Cerus Appoints William "Obi" Greenman as Chief Business Officer
[ 05:30 AM ] - Market Wire
Data on VIVITROL® to be Presented at Upcoming American Psychiatric Association Annual Meeting
[ 05:30 AM ] - Market Wire
Vicor Technologies Announces Results of PD2i(R) Analysis of MUSIC Trial Data
[ 05:00 AM ] - Market Wire
Curis Added to NASDAQ Biotechnology Index
[ 04:30 AM ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study
[ 04:30 AM ] - Market Wire
Geron Announces Positive Data on Its Small Molecu .. tivator in Model of Idiopathic Pulmonary Fibrosis
[ 04:08 AM ] - Market Wire
Roche en Biogen Idec maken bekend te stoppen met .. r ocrelizumab bij patinten met reumatode artritis
[ 04:05 AM ] - Market Wire
Roche y Biogen Idec interrumpen el programa de de .. ocrelizumab en pacientes con artritis reumatoide
[ 04:00 AM ] - Market Wire
MEDNAX Announces the Acquisition of Neonatal Practices
[ 04:00 AM ] - Market Wire
00 am Eastern; Webcast Will Be Available
[ 03:05 AM ] - Market Wire
Health Management Associates, Inc. to Present at The 2010 CITI Global Healthcare Conference
[ 03:00 AM ] - Market Wire
BIOLASE Announces Multiple Allegations in Recent Lawsuit Are Dropped
[ 02:39 AM ] - Market Wire
Roche et Biogen Idec annoncent leur d©cision d'a .. ement clinique de l'ocrelizumab chez les patients
[ 02:30 AM ] - Market Wire
Wellstar International, Inc. Announces Installation and Training Completed
[ 01:18 AM ] - Market Wire
Roche und Biogen Idec geben ihre Entscheidung fr .. ntwicklungsprogramms fr Ocrelizumab bei Patienten
Tue, May 18, 2010
[ 10:00 PM ] - Market Wire
Roche e Biogen Idec annunciano di aver deciso di .. sviluppo clinico dell'ocrelizumab nei pazienti af
[ 06:00 PM ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. of Shareholders of Virtual Radiologic Corporation
[ 04:25 PM ] - Market Wire
Akela Pharma files its third Default Status Report
[ 03:16 PM ] - Market Wire
Aberdeen International Reports Value of Investmen .. d Cash of $0.80 Per Share at End of First Quarter
[ 02:05 PM ] - Market Wire
Kindred Healthcare Announces Voting Results for the 2010 Annual Meeting of Shareholders
[ 01:20 PM ] - Market Wire
Court Approves Emeritus/Blackstone Joint Venture .. s Successful Bidder in Sunwest Bankruptcy Auction
[ 01:18 PM ] - Market Wire
Conceptus(R) Receives FDA Approval on Essurea?s Bilateral Placement Rate to 96.9%
[ 01:15 PM ] - Market Wire
Baxter to Present at the 2010 Citi Investment Research Global Health Care Conference
[ 01:05 PM ] - Market Wire
TomoTherapy to Present at Two Upcoming Investment Conferences
[ 01:05 PM ] - Market Wire
Illumina Receives FDA 510(k) Clearance for VeraCo .. for Factor V (Leiden) and Factor II (Prothrombin)
[ 01:00 PM ] - Market Wire
TomoTherapy EMEA User Education Symposium Brings .. ether Users Throughout Europe and the Middle East
[ 12:58 PM ] - Market Wire
Millipore Corporation named to Globe 100
[ 11:09 AM ] - Market Wire
Cardiovascular Systems to Present at the 2010 Cit .. Investment Research Global Health Care Conference
[ 11:00 AM ] - Market Wire
Aetna Wins Two National ClearMark Awards from the Center for Plain Language
[ 10:26 AM ] - Market Wire
Covidien introduceert hechtingsapparaat SILS voor geavanceerde laparoscopie

Covidien introduceert hechtingsapparaat SILS voor geavanceerde laparoscopie


Published on 2010-05-18 10:30:24 - Market Wire
  Print publication without navigation


NORTH HAVEN, Conn.--([ BUSINESS WIRE ])--Covidien (NYSE: COV), een toonaangevende internationale leverancier van gezondheidszorgproducten, introduceert vandaag hechtingsapparaat SILS voor geavanceerde laparoscopie met enkelvoudige incisies. Hiermee is de productlijn van het bedrijf uitgebreid. De nieuwe generatie endoscopische technologie biedt meer toegang en maneuverabiliteit. Het nieuwe SILS hechtingsinstrument is het enige geautomatiseerde hechtingsapparaat met knikfunctie en draaitop voor optimale flexibiliteit. Deze unieke combinatie brengt endoscopisch hechten op het volgende niveau.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Contributing Sources